Inspira Technologies Oxy B.H.N. Ltd. announced a joint development agreement with Qarakal Quantum Ltd. The partnership will integrate Inspira’s Additively Manufactured Electronics (AME) platform, branded QTREX, into a superconducting quantum environment.
The agreement establishes a multi‑phase engineering program to test and evaluate Inspira’s AME technology under cryogenic conditions. Qarakal will provide the technical requirements, while Inspira will supply 3D‑printed conductive and insulating structures for high‑density routing, embedded shielding, and compact interconnect geometries suitable for dilution refrigerators.
This collaboration addresses a critical bottleneck in quantum computing—high‑density, thermally optimized connectivity—potentially opening a new revenue stream and expanding Inspira’s presence in the rapidly growing quantum technology sector. Inspira continues to develop its medical technology business, including the INSPIRA ART100 system and HYLA blood sensor, but the quantum partnership signals a strategic pivot toward high‑growth hardware infrastructure.
CEO Dagi Ben‑Noon emphasized that the agreement places Inspira’s technology in a real‑world quantum development environment, allowing performance evaluation under relevant cryogenic conditions. The structured technical collaboration will provide measurable execution against defined metrics, reinforcing Inspira’s focus on tangible value creation in quantum infrastructure.
By validating QTREX in a superconducting quantum setting, Inspira positions itself to capture a share of the quantum hardware infrastructure market, while its existing medical device revenue remains modest but growing, with a $49.5 million binding order for the ART100 system expected to convert to revenue in 2026. The partnership also aligns with Inspira’s broader strategy to potentially rebrand as QTREX Ltd. to reflect its quantum focus.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.